FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2057415024> ?p ?o ?g. }

• W2057415024 endingPage "4218" @default.
• W2057415024 startingPage "4066" @default.
• W2057415024 abstract "Human cytochrome P450 1A2 (CYP1A2) is one of the major CYPs in the liver ( approximately 13%) and metabolizes about 20% of clinically used drugs. CYP1A2 is a 515-residue protein with a molecular mass of 58,294 Dal. The recently published crystal structure of CYP1A2 in complex with alpha-naphthoflavone has showed a rather compact active site with a relatively small volume of the cavity of 375 A(3), which is 44.2% and 49.3% larger than that of CYP2A6 (260 A(3)) and CYP2E1 (190 A(3)), respectively. A series of residues in the substrate recognition regions of CYP1A2 (e.g. Arg108, Thr124, Thr223, Glu225, Phe226, Lys250, Arg251, Lys253, Asn312, Asp313, Glu318, Thr319, Asp320, Thr321, Val322, Leu382, Thr385, and Ile386) have been shown to play important roles in ligand-enzyme binding based on site-directed mutagenesis and homology modeling studies. Typical CYP1A2 substrates generally contain planar ring that can fit the narrow and planar active site of the enzyme, such as propranolol, clozapine, guanabenz, flutamide, imatinib, thalidomide, carbamazepine, lidocaine, theophylline, tacrine, tizanidine, zolpidem, riluzole, zileuton, and leflunomide. CYP1A2 is one of the major enzymes that bioactivate a number of procarcinogens including polycyclic aromatic hydrocarbons (e.g., benzo[a]pyrene), heterocyclic aromatic amines/amides (e.g. 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine), mycotoxins (e.g. aflatoxin B(1)) and some natural compounds such as aristolochic acids present in several Chinese herbal medicines. This enzyme also metabolizes several important endogenous compounds including retinols, melatonin, steroids, uroporphyrinogen and arachidonic acids. Like many of other CYPs, CYP1A2 is subject to induction and inhibition by a number of compounds. In particular, several therapeutic drugs including antofloxacin, carbamazepine, dihydralazine, furafylline, isoniazid, rofecoxib, clorgyline, thiabendazole, and zileuton are mechanism-based inhibitors of CYP1A2. Reversible and irreversible inhibition of by drugs CYP1A2 may provide an explanation for some clinical drug-drug interactions. Similar to CYP1A1 and 1B1, CYP1A2 is primarily regulated by the aromatic hydrocarbon receptor (AhR), a ligand-activated transcription factor and a basic helix-loop-helix protein belonging to the Per-Arnt-Sim family of transcription factors. CYP1A2 is polymorphic and a number of genetic mutations in CYP1A2 have been reported. It has been suggested that approximately 35 to 75% of the interindividual variability in CYP1A2 activity is due to genetic factors. Some of the mutations of CYP1A2 have been found to alter the clearance of drugs that are extensively metabolized by CYP1A2. Collectively, CYP1A2 plays a major role in drug metabolism, procarcinogen activation and some drug-drug interactions; it is important to identify whether a new drug is a substrate, inducer or inhibitor in drug development. This candidate selection might eventually lead to a less prominent role of this enzyme in the future for drug metabolism and minimize the potential for significant polymorphic metabolism in humans and drug-drug interactions when used in combination with CYP1A2 inhibitors." @default.
• W2057415024 created "2016-06-24" @default.
• W2057415024 creator A5042873784 @default.
• W2057415024 creator A5060941733 @default.
• W2057415024 date "2009-11-01" @default.
• W2057415024 modified "2023-10-15" @default.
• W2057415024 title "Synthetic and Natural Compounds that Interact with Human Cytochrome P450 1A2 and Implications in Drug Development" @default.
• W2057415024 doi "https://doi.org/10.2174/092986709789378198" @default.
• W2057415024 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19754423" @default.
• W2057415024 hasPublicationYear "2009" @default.
• W2057415024 type Work @default.
• W2057415024 sameAs 2057415024 @default.
• W2057415024 citedByCount "97" @default.
• W2057415024 countsByYear W20574150242012 @default.
• W2057415024 countsByYear W20574150242013 @default.
• W2057415024 countsByYear W20574150242014 @default.
• W2057415024 countsByYear W20574150242015 @default.
• W2057415024 countsByYear W20574150242016 @default.
• W2057415024 countsByYear W20574150242017 @default.
• W2057415024 countsByYear W20574150242018 @default.
• W2057415024 countsByYear W20574150242019 @default.
• W2057415024 countsByYear W20574150242020 @default.
• W2057415024 countsByYear W20574150242021 @default.
• W2057415024 countsByYear W20574150242022 @default.
• W2057415024 countsByYear W20574150242023 @default.
• W2057415024 crossrefType "journal-article" @default.
• W2057415024 hasAuthorship W2057415024A5042873784 @default.
• W2057415024 hasAuthorship W2057415024A5060941733 @default.
• W2057415024 hasConcept C181199279 @default.
• W2057415024 hasConcept C185592680 @default.
• W2057415024 hasConcept C196013638 @default.
• W2057415024 hasConcept C526171541 @default.
• W2057415024 hasConcept C55493867 @default.
• W2057415024 hasConcept C71240020 @default.
• W2057415024 hasConcept C86745063 @default.
• W2057415024 hasConcept C86803240 @default.
• W2057415024 hasConcept C98274493 @default.
• W2057415024 hasConceptScore W2057415024C181199279 @default.
• W2057415024 hasConceptScore W2057415024C185592680 @default.
• W2057415024 hasConceptScore W2057415024C196013638 @default.
• W2057415024 hasConceptScore W2057415024C526171541 @default.
• W2057415024 hasConceptScore W2057415024C55493867 @default.
• W2057415024 hasConceptScore W2057415024C71240020 @default.
• W2057415024 hasConceptScore W2057415024C86745063 @default.
• W2057415024 hasConceptScore W2057415024C86803240 @default.
• W2057415024 hasConceptScore W2057415024C98274493 @default.
• W2057415024 hasIssue "31" @default.
• W2057415024 hasLocation W20574150241 @default.
• W2057415024 hasLocation W20574150242 @default.
• W2057415024 hasOpenAccess W2057415024 @default.
• W2057415024 hasPrimaryLocation W20574150241 @default.
• W2057415024 hasRelatedWork W1943654482 @default.
• W2057415024 hasRelatedWork W1981721544 @default.
• W2057415024 hasRelatedWork W1995322872 @default.
• W2057415024 hasRelatedWork W2033644570 @default.
• W2057415024 hasRelatedWork W2040222743 @default.
• W2057415024 hasRelatedWork W2056277985 @default.
• W2057415024 hasRelatedWork W2057322399 @default.
• W2057415024 hasRelatedWork W2064104740 @default.
• W2057415024 hasRelatedWork W2085583693 @default.
• W2057415024 hasRelatedWork W2167227549 @default.
• W2057415024 hasVolume "16" @default.
• W2057415024 isParatext "false" @default.
• W2057415024 isRetracted "false" @default.
• W2057415024 magId "2057415024" @default.
• W2057415024 workType "article" @default.